Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Dawnrays Pharmaceutical Holdings Ltd. ( (HK:2348) ) has shared an announcement.
Dawnrays Pharmaceutical (Holdings) Ltd. has declared a final ordinary dividend of HKD 0.048 per share for the financial year ended 31 December 2025, subject to shareholder approval at the annual general meeting on 22 May 2026. The company has set the ex-dividend date for 27 May 2026, with the books closing from 29 May to 1 June, a record date of 1 June, and dividend payment scheduled for 12 June 2026, signaling continued capital returns to shareholders and providing clarity on key entitlement timelines.
The most recent analyst rating on (HK:2348) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on Dawnrays Pharmaceutical Holdings Ltd. stock, see the HK:2348 Stock Forecast page.
More about Dawnrays Pharmaceutical Holdings Ltd.
Dawnrays Pharmaceutical (Holdings) Ltd. is a Hong Kong-listed pharmaceutical company. It operates in the healthcare sector, focusing on the development, production, and sale of pharmaceutical products, serving patients and medical markets primarily in Greater China and potentially other international markets.
Average Trading Volume: 192,033
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.67B
See more insights into 2348 stock on TipRanks’ Stock Analysis page.